Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas.
Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas.
复制标题
Gli促进人肺腺癌上皮间质转化
DOI:
10.18632/oncotarget.11246
复制
发表时间:
2016-12-06
期刊:
影响因子:
--
通讯作者:
He B
中科院分区:
文献类型:
--
作者:
Li H;Yue D;Jin JQ;Woodard GA;Tolani B;Luh TM;Giroux-Leprieur E;Mo M;Chen Z;Che J;Zhang Z;Zhou Y;Wang L;Hao X;Jablons D;Wang C;He B
Adenocarcinoma is the most common type of lung cancer. Epithelial-mesenchymal transition (EMT) is required for tumor invasion/metastasis and the components that control this process are potential therapeutic targets. This study we examined the role of Gli in lung adenocarcinoma and whether its activation regulates metastasis through EMT in lung adenocarcinoma. We found that tumors with high Gli expression had significantly lower E-Cadherin expression in two independent cohorts of patients with lung adenocarcinoma that we studied. In vitro up-regulation of SHh resulted in increased cell migration while small molecule inhibitors of Smo or Gli significantly reduced cell mobility both in a wound healing assay and in a 3D cell invasion assay. Inhibition of Gli in vivo decreased tumor growth and induced an increase in E-Cadherin expression. Our results indicate that Gli may be critical for lung adenocarcinoma metastasis and that a novel Gli inhibitor shows promise as a therapeutic agent by preventing cell migration and invasion in vitro and significantly reducing tumor growth and increasing E-Cadherin expression in vivo.